Connetics Corporation has entered into an agreement with ALZA Corporation to develop an advanced drug delivery system for Connetics’ proprietary recombinant human relaxin drug candidate. The development work will focus on applying ALZA’s implantable drug delivery technology, or DUROS system, to expand delivery options for relaxin. The current delivery system for Connetics’ relaxin formulation involves Read more about Connetics And ALZA Announce Drug Delivery Collaboration[…]